Stands and residential land for sale in Mutare, Manicaland, offer a range of options with an average price of $82,500. The median land area for these properties is about 1,434 ㎡, with some larger plots available up to 1,000,000 ㎡, providing opportunities for various types of developments and budgets.
Many of the land parcels come with municipal water access, which is a key feature for residential development. These properties typically provide a blank canvas for buyers interested in building homes or investing in land in a growing urban area.
Mutare is the third-largest city in Zimbabwe and the capital of Manicaland Province, known for its cooler climate and scenic surroundings in the Eastern Highlands. The city offers good access to schools like Mutare Polytechnic, healthcare facilities including Mutare Provincial Hospital, and shopping centers such as Mutare Shopping Centre and Mutare City Mall. Transport connections by road and rail link Mutare to Harare and Mozambique, making it a strategic location for residents and investors alike. Nearby attractions like the Vumba Botanical Gardens and Bvumba Mountains add to the appeal for those seeking a balanced lifestyle with natural beauty and urban convenience.
| Type | Avg. price |
|---|---|
| Average price | $82,500 |
Prices as of October 2026
Buying a housing stand in Zimbabwe? Inspect title deeds, subdivision permits, compliance certificates, and seller IDs before making any payment.
Can someone claim your land in Zimbabwe? Learn how 30 year acquisitive prescription works, the legal risks involved, and how to protect your property title.
Explore October 2026 Property Pulse insights on the Zimbabwean real estate market, where high buyer demand outpaces limited housing supply across major areas.
Built a house on land registered in your partner's name? Learn your legal rights in Zimbabwe, tacit universal partnerships, and unjust enrichment claims.
Planning to convert or buy commercial property? Understand Zimbabwe’s change of use rules, 2026 Harare fees, timelines and approval risks.